| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
42,157 | 33,790 | 49,972 | 9,585 | 6,611 | ||
General and administrative | ||||||
19,251 | 19,141 | 15,035 | 12,949 | 6,578 | ||
Total operating expenses | ||||||
61,409 | 52,931 | 65,007 | 22,535 | 13,190 | ||
Loss from operations | ||||||
-61,409 | -52,931 | -65,007 | -22,535 | -13,190 | ||
Interest income | ||||||
948 | 952 | 201 | 120 | 30 | ||
Net loss | ||||||
-60,461 | -51,979 | -64,806 | -22,414 | -13,160 | ||
Net loss attributable to common stockholders | ||||||
-60,461 | -51,979 | -64,806 | -22,414 | -13,160 | ||
Net loss per share, basic and diluted | ||||||
- | - | -3.35 | -2.28 | -1.36 | ||
Weighted-average shares outstanding basic and diluted | ||||||
- | - | 19,344 | 9,838 | 9,699 | ||
Common Stock [Member] | ||||||
Net loss per share, basic and diluted | ||||||
-1.54 | -2.11 | - | - | - | ||
Weighted-average shares outstanding basic and diluted | ||||||
39,217 | 24,631 | - | - | - | ||